Recombinant Rat TIM-3 Fc Chimera Protein, CF Summary
Details of Functionality |
Measured by its binding ability in a functional ELISA. When Recombinant Human Galectin-9 Protein
(Catalog #
2045-GA) is immobilized at 1.0 µg/mL (100 µL/ well), Recombinant Rat TIM‑3 Fc Chimera (Catalog # 10489-TM) that produces a 50% optimal binding response is found to be 20-120 ng/mL |
Source |
Mouse myeloma cell line, NS0-derived rat TIM-3 protein
Rat TIM-3 (Leu22-Ala194) Accession # P0C0K5.2 | IEGRMD | Mouse IgG1 (Pro100-Lys330) | N-terminus | | C-terminus | |
|
Accession # |
|
N-terminal Sequence |
Leu22 |
Structure / Form |
Disulfide-linked homodimer |
Protein/Peptide Type |
Recombinant Proteins |
Purity |
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. |
Endotoxin Note |
<0.10 EU per 1 μg of the protein by the LAL method. |
Applications/Dilutions
Dilutions |
|
Theoretical MW |
46 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
SDS-PAGE |
60-75 kDa, under reducing conditions |
Packaging, Storage & Formulations
Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 3 months, -20 to -70 °C under sterile conditions after reconstitution.
|
Buffer |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. |
Purity |
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. |
Reconstitution Instructions |
Reconstitute at 250 μg/mL in PBS. |
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Recombinant Rat TIM-3 Fc Chimera Protein, CF
Background
T cell immunoglobulin and mucin domain-3 (TIM-3) also known
as HAVCR2, is a member of the TIM family of immune regulating molecules. TIMs
are type I transmembrane glycoproteins with one Ig-like V-type domain, a
Ser/Thr-rich mucin stalk region (1, 2). While lacking a specific immunoreceptor tyrosine-based inhibition motif (ITIM), the cytoplasmic
domain of TIM-3 contains a conserved
region of five tyrosine residues important for downstream signaling (3). A soluble form of TIM-3 lacking the mucin stalk and
transmembrane domains is formed as either a result of alternative splicing or metalloproteinase-dependent
cleavage. Within the ECD, mature rat TIM-3 shares 60% and 69% amino acid
sequence identity with human and mouse TIM-3, respectively. TIM-3 is up‑regulated
on several populations of activated myeloid cells (macrophage, monocyte,
dendritic cell, microglia, mast cell) and T cells (Th1, CD8+, NK,
Treg) (3-10). Its binding to Galectin-9 induces a range of immunosuppressive
functions which enhance immune tolerance and inhibit anti-tumor immunity (3,11).
TIM-3 ligation attenuates CD8+ and Th1 cell responses (11-13)
and promotes the activity of Treg and myeloid derived suppressor cells (8, 11,
13, 14). In addition, dendritic cell-expressed TIM-3 dampens inflammation by
enabling the phagocytosis of apoptotic cells and the cross-presentation of
apoptotic cell antigens (4). It also binds the alarmin HMGB1, thereby
preventing the activation of TLRs in response to released tumor cell DNA (7).
TIM-3 interactions with Galectin-9 can alternatively trigger immune stimulatory
effects, such as the coactivation of NK cell cytotoxicity (10).
- Sakuishi, K. et al. (2011) Trends Immunol. 32:345.
- Anderson, A.C. (2012) Curr. Opin. Immunol. 24:213.
- Wolf, Y. et al. (2020) Nature Reviews Immunology 20:173.
- Nakayama, M. et al. (2009) Blood 113:3821.
- Anderson, A.C. et al. (2007) Science 318:1141.
- Wiener, Z. et al. (2007) J. Invest. Dermatol. 127:906.
- Chiba, S. et al. (2012) Nat. Immunol. 13:832.
- Sanchez-Fueyo, A. et al. (2003) Nat. Immunol. 4:1093.
- Ndhlovu, L.C. et al. (2012) Blood 119:3734.
- Gleason, M.K. et al. (2012) Blood 119:3064.
- Zhu, C. et al. (2005) Nat. Immunol. 6:1245.
- Sakhdari, A. et al. (2012) PLoS ONE 7:e40146.
- Sabatos, C.A. et al. (2003) Nat. Immunol. 4:1102.
- Dardalhon, V. et al. (2010) J. Immunol. 185:1383.
Customers Who Viewed This Item Also Viewed...
Species: Hu
Applications: ICC, IHC, WB
Species: Mu
Applications: WB
Species: Ca, Hu, Mu, Po, Rb, Rt
Applications: Dual ISH-IHC, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, Simple Western, WB
Species: Hu
Applications: Block, CyTOF-ready, Dual ISH-IHC, ELISA(Cap), ELISA(Det), ELISA(Sta), Flow, IHC, WB
Species: Hu
Applications: IHC, IHC-P, IP, WB
Species: Hu
Applications: IHC, IHC-P, PEP-ELISA, WB
Species: Hu
Applications: BA
Species: Hu, Mu, Rt
Applications: ELISA, Flow, ICC/IF, IHC, IHC-P, WB
Species: Mu, Rt
Applications: Cell Depl, CyTOF-ready, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, IP, InhibTFunc
Species: Hu, Mu
Applications: IHC, WB
Species: Hu
Applications: BA
Species: Hu
Applications: BA
Species: Hu
Applications: BA
Species: Mu
Applications: ELISA
Species: Hu
Applications: CyTOF-ready, ELISA, Flow, ICC/IF, IHC, IHC-P, PA, WB
Species: Hu, Mu
Applications: Flow-IC, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, IP, WB
Species: Bv, Hu, Mu, Rt
Applications: Dual ISH-IHC, Flow, IB, ICC/IF, IHC, IHC-P, IP, Single-Cell Western, WB
Species: Hu
Applications: IHC, WB
Species: Hu
Applications: BA
Species: Rt
Applications: Bioactivity
Publications for TIM-3 (10489-TM) (0)
There are no publications for TIM-3 (10489-TM).
By submitting your publication information earn gift cards and discounts for future purchases.
Reviews for TIM-3 (10489-TM) (0)
There are no reviews for TIM-3 (10489-TM).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
- Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
- Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
FAQs for TIM-3 (10489-TM) (0)